Trademark: 97063862
Status Date
Friday, December 15, 2023
Filing Date
Thursday, October 7, 2021
5 Pharmaceutical preparations, namely, drug formulations for use in neurological and central nervous system treatment regimens
10 Drug delivery system, namely, medical device for administering drugs for treatment of neurological and central nervous system disorders; medical device for administering drugs for treatment of neurological and central nervous system disorders
Dec 15, 2023
Notification Of Letter Of Suspension E-Mailed
Dec 15, 2023
Letter Of Suspension E-Mailed
Dec 15, 2023
Suspension Letter Written
Dec 11, 2023
Teas Request For Reconsideration Received
Dec 11, 2023
Ex Parte Appeal-Instituted
Dec 11, 2023
Jurisdiction Restored To Examining Attorney
Dec 11, 2023
Exparte Appeal Received At Ttab
Sep 11, 2023
Application Extension Granted/Receipt Provided
Sep 11, 2023
Application Extension To Response Period - Received
Jun 10, 2023
Notification Of Final Refusal Emailed
Jun 10, 2023
Final Refusal E-Mailed
Jun 10, 2023
Final Refusal Written
May 16, 2023
Teas/Email Correspondence Entered
May 15, 2023
Correspondence Received In Law Office
May 15, 2023
Teas Response To Office Action Received
Feb 14, 2023
Notification Of Non-Final Action E-Mailed
Feb 14, 2023
Non-Final Action E-Mailed
Feb 14, 2023
Non-Final Action Written
Jan 14, 2023
Teas/Email Correspondence Entered
Jan 13, 2023
Correspondence Received In Law Office
Jan 13, 2023
Teas Response To Office Action Received
Jul 13, 2022
Notification Of Non-Final Action E-Mailed
Jul 13, 2022
Non-Final Action E-Mailed
Jul 13, 2022
Non-Final Action Written
Jul 12, 2022
Assigned To Examiner
Nov 1, 2021
New Application Office Supplied Data Entered
Oct 11, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
